Page last updated: 2024-11-06

pinocembrin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Pinocembrin is a natural flavonoid found in various plants, including honey, propolis, and red wine. It is known for its antioxidant and anti-inflammatory properties. Pinocembrin has been studied for its potential health benefits, such as its neuroprotective effects, its ability to reduce blood pressure, and its anti-cancer activity. Researchers are interested in exploring the potential therapeutic uses of pinocembrin in treating conditions such as Alzheimer's disease, heart disease, and cancer. Pinocembrin can be synthesized in the laboratory, but it is also possible to extract it from natural sources. '

pinocembrin : A dihydroxyflavanone in which the two hydroxy groups are located at positions 5 and 7. A natural product found in Piper sarmentosum and Cryptocarya chartacea. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
CryptocaryagenusA plant genus of the family LAURACEAE. Members contain cryptofolione, caryachine, grandisin and other compounds. Some PEUMUS species have been reclassified as CRYPTOCARYA.[MeSH]LauraceaeA family of mainly aromatic evergreen plants in the order Laurales. The laurel family includes 2,200 species in 45 genera and from these are derived medicinal extracts, essential oils, camphor and other products.[MeSH]
PipergenusA plant genus of the family PIPERACEAE that includes species used for spicy and stimulating qualities.[MeSH]PiperaceaeA family of flowering plants in the order Piperales best known for the black pepper widely used in SPICES, and for KAVA and Betel used for neuroactive properties.[MeSH]
Piper sarmentosumspecies[no description available]PiperaceaeA family of flowering plants in the order Piperales best known for the black pepper widely used in SPICES, and for KAVA and Betel used for neuroactive properties.[MeSH]

Cross-References

ID SourceID
PubMed CID68071
CHEMBL ID399910
CHEBI ID28157
SCHEMBL ID10026578
MeSH IDM0065808
PubMed CID238782
CHEMBL ID70518
SCHEMBL ID291899
MeSH IDM0065808

Synonyms (116)

Synonym
(+)-pinocoembrin
BRD-K94689771-001-02-5
nsc-43318
DIVK1C_006992
SDCCGMLS-0066749.P001
OPREA1_508274
SPECTRUM5_000349
(s)-2,3-dihydro-5,7-dihydroxy-2-phenyl-4h-1-benzopyran-4-one
4h-1-benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-phenyl-, (-)-
nsc 43318
nsc 661207
4h-1-benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-phenyl-, (s)-
nsc 279005
SPECTRUM_001879
SPECTRUM4_001765
BSPBIO_003329
dihydrochrysin
(2s)-5,7-dihydroxy-2-phenyl-chroman-4-one
galangin flavanone
NSC661207 ,
nsc43318
4h-1-benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-phenyl-, (s)-(-)-
nsc-279005
C09827
480-39-7
pinocembrin
MLS000697595
smr000232372
MLS000728654
KBIOSS_002406
KBIO2_007537
KBIO1_001936
KBIO2_004969
KBIOGR_002249
KBIO2_002401
KBIO3_002549
SPECTRUM3_001635
SPECTRUM2_001670
SPECPLUS_000896
SPBIO_001859
NCGC00178137-01
(s)-5,7-dihydroxyflavanone
(2s)-5,7-dihydroxy-2-phenyl-3,4-dihydro-2h-1-benzopyran-4-one
chembl399910 ,
bdbm26667
(2s)-pinocembrin
LMPK12140214
chebi:28157 ,
(2s)-5,7-dihydroxy-2-phenyl-2,3-dihydrochromen-4-one
(2s)-5,7-dihydroxy-2-phenyl-2,3-dihydro-4h-chromen-4-one
AKOS004111068
8t7c8ch791 ,
unii-8t7c8ch791
4h-1-benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-phenyl-, (2s)-
HMS2205J20
S3941
(s)-pinocembrin
CCG-39668
URFCJEUYXNAHFI-ZDUSSCGKSA-N
SCHEMBL10026578
(+)-pinocembrin
AC-34601
(s)-5,7-dihydroxy-2-phenylchroman-4-one
DTXSID3075412
pinocembrin (6ci)
SR-01000762561-3
sr-01000762561
pinocembrin, analytical standard, 95% (tlc), solid
CS-0009111
HY-N0575
AS-56293
XP162085
(2~{s})-5,7-bis(oxidanyl)-2-phenyl-2,3-dihydrochromen-4-one
STL578139
68745-38-0
nsc-661207
MEGXP0_000456
ACON1_000231
NCGC00180757-01
NSC279005 ,
4h-1-benzopyran-4-one,3-dihydro-5,7-dihydroxy-2-phenyl-, (s)-
4h-1-benzopyran-4-one,3-dihydro-5,7-dihydroxy-2-phenyl-, (-)-
5,7-dihydroxyflavanone
smr000440642
MLS000877016
5,7-dihydroxy-2-phenyl-chroman-4-one
BRD-A84450718-001-01-4
5,7-dihydroxy-2-phenyl-2,3-dihydrochromen-4-one
CHEMBL70518
HMS2267H13
FT-0630778
5,7-dihydroxy-2-phenylchroman-4-one
AKOS015895182
HMS3330B01
SCHEMBL291899
mfcd00017482
(+/-)-pinocembrin
AC-35131
5,7-dihydroxy-2-phenyl-2,3-dihydro-4h-chromen-4-one #
FT-0698458
( inverted exclamation marka)-pinocembrin
DTXSID80285959
A871991
bdbm243060
ptp inhibitor, 4l
rac-pinocembrin
pinocembrin (racemic)
Q748200
SB17302
(+/-)-5,7-dihydroxyflavanone; nsc 43318
dl-0108
()-5,7-dihydroxyflavanone; nsc 43318
()-pinocembrin
HY-N2540
CS-0022812
FS-7859

Research Excerpts

Overview

Pinocembrin is a natural favonoid compound, which can be extracted from honey, propolis and several other plants. Pinocembri is a major flavonoid molecule incorporated as multifunctional in the pharmaceutical industry.

ExcerptReferenceRelevance
"Pinocembrin is a dihydroflavonoid, which is widely found in several plant species. "( Synthesis of Novel Pinocembrin Amino Acid Derivatives and Their Antiaging Effect on
Du, Y; Feng, X; Jiang, K; Liu, C; Liu, Y; Pang, X; Wang, W; Wang, X, 2021
)
2.39
"Pinocembrin is a natural favonoid compound, which can be extracted from honey, propolis and several other plants."( Pinocembrin ameliorates acute liver failure via activating the Sirt1/PPARα pathway in vitro and in vivo.
Cao, P; Chen, Q; Gong, Z; Pei, M; Shi, C; Wang, L, 2022
)
2.89
"Pinocembrin (PB) is a kind of flavonoid molecule isolated from honey and propolis and has antimicrobial, anti-inflammatory, antioxidant, and anticancer function."( Pinocembrin mitigates depressive-like behaviors induced by chronic unpredictable mild stress through ameliorating neuroinflammation and apoptosis.
Gu, X; Tu, J; Wang, W; Xu, L; Zheng, L, 2020
)
2.72
"Pinocembrin is a natural flavonoid that may exert protective effects on osteocytes."( Pinocembrin alleviates glucocorticoid-induced apoptosis by activating autophagy via suppressing the PI3K/Akt/mTOR pathway in osteocytes.
Gong, LJ; Huang, JM; Jiang, C; Wang, XY; Yan, ZQ, 2020
)
2.72
"Pinocembrin is a flavonoid with anti-inflammatory effects."( Pinocembrin relieves lipopolysaccharide and bleomycin induced lung inflammation via inhibiting TLR4-NF-κB-NLRP3 inflammasome signaling pathway.
Cui, M; Cui, Y; Gan, W; Helian, K; Li, X; Liu, R; Ning, W; Ren, S; Wang, M; Wei, Y; Xiao, T; Yang, C; Zhou, H, 2021
)
2.79
"Pinocembrin (PINO) is a natural flavonoid retaining anti-microbial, anti-oxidant, and anti-inflammatory activities."( Protective and therapeutic effects of the flavonoid "pinocembrin" in indomethacin-induced acute gastric ulcer in rats: impact of anti-oxidant, anti-inflammatory, and anti-apoptotic mechanisms.
El-Demerdash, AA; Elsherbiny, DA; Esmat, A; Menze, ET; Tadros, MG, 2021
)
1.59
"Pinocembrin (PCB) is a natural flavonoid extracted as a pure molecule from honey, propolis, and some plants."( Pinocembrin Reduces Arthritic Symptoms in Mouse Model via Targeting Sox4 Signaling Molecules.
Ahmed, EA; Ibrahim, HM; Khalil, HE, 2021
)
2.79
"Pinocembrin is a natural flavanone with versatile biological and pharmacological activities."( Pinocembrin induces ER stress mediated apoptosis and suppresses autophagy in melanoma cells.
Chen, X; Chen, Y; Hu, CW; Hu, F; Wang, K; Wu, Y; Zheng, Y, 2018
)
2.64
"Pinocembrin is a major flavonoid molecule incorporated as multifunctional in the pharmaceutical industry."( Pinocembrin: a novel natural compound with versatile pharmacological and biological activities.
Ali Eltayb, W; Ali, M; Li, J; Li, X; Millimouno, FM; Rasul, A, 2013
)
2.55
"Pinocembrin is a flavonoid that exhibits diverse biological properties. "( Biosynthesis of pinocembrin from glucose using engineered escherichia coli.
Ahn, JH; Kim, BG; Lee, H, 2014
)
2.19
"Pinocembrin is a major flavonoid molecule isolated from honey and propolis. "( Pinocembrin attenuates hippocampal inflammation, oxidative perturbations and apoptosis in a rat model of global cerebral ischemia reperfusion.
Abdel Salam, RM; Attia, AS; Kenawy, SA; Saad, MA, 2015
)
3.3
"Pinocembrin is a natural flavonoid compound extracted from honey, propolis, ginger roots, wild marjoram, and other plants. "( The Natural Flavonoid Pinocembrin: Molecular Targets and Potential Therapeutic Applications.
Lan, X; Li, Q; Wang, J; Wang, W, 2016
)
2.19
"(2S)-Pinocembrin is a chiral flavanone with versatile pharmacological and biological activities. "( Transcriptome-enabled discovery and functional characterization of enzymes related to (2S)-pinocembrin biosynthesis from Ornithogalum caudatum and their application for metabolic engineering.
Chen, X; Guo, L; Kong, JQ; Li, LN; Pan, YT; Tang, W, 2016
)
1.17
"Pinocembrin is a major flavonoid found in rhizomes of fingerroot (Boesenbergia pandurata)."( Pinocembrin attenuates gentamicin-induced nephrotoxicity in rats.
Arjinajarn, P; Chatsudthipong, V; Chattipakorn, N; Jaikumkao, K; Lungkaphin, A; Pompimon, W; Pongchaidecha, A; Promsan, S, 2016
)
2.6
"Pinocembrin is a flavonoid that has been reported to exhibit various pharmacological and biological activities including antimicrobial, antioxidant, and anti-inflammatory. "( Pinocembrin attenuates lipopolysaccharide-induced inflammatory responses in Labeo rohita macrophages via the suppression of the NF-κB signalling pathway.
Giri, SS; Park, SC; Sen, SS; Sukumaran, V, 2016
)
3.32

Effects

Pinocembrin has a variety of pharmacological activities, such as neuroprotective effect, antimicrobial activity, and antioxidant efficacy. It has been widely used in the therapy of cancer and other diseases due to its anti-inflammatory, anti-allergic,. anti-oxidant,Anti-carcinogenic, and anti-viral activities.

ExcerptReferenceRelevance
"Pinocembrin has a variety of pharmacological activities, such as neuroprotective effect, antimicrobial activity, and antioxidant efficacy."( [Progress in synthetic biology of pinocembrin].
Guo, L; Kong, J, 2015
)
1.42
"Pinocembrin (Pin) has been confirmed to exert anti-inflammatory and antiatherosclerotic effects. "( Pinocembrin suppresses oxidized low-density lipoprotein-triggered NLRP3 inflammasome/GSDMD-mediated endothelial cell pyroptosis through an Nrf2-dependent signaling pathway.
Pan, T; Tian, H; Wang, S; Wang, T; Wu, Y; Yao, S; Yu, H, 2022
)
3.61
"Pinocembrin has been shown to have neuroprotective effects, while the therapeutic functions under IH condition are still unknown."( Pinocembrin ameliorates intermittent hypoxia-induced neuroinflammation through BNIP3-dependent mitophagy in a murine model of sleep apnea.
Gong, LJ; Gu, WY; Wang, XY; Wu, X, 2020
)
2.72
"Pinocembrin (Pino) has been widely used in the therapy of cancer and other diseases due to its anti-inflammatory, anti-allergic, anti-oxidant, anti-carcinogenic, and anti-viral activities."( Pinocembrin alleviates cognition deficits by inhibiting inflammation in diabetic mice.
Pei, B; Sun, J, 2018
)
2.64
"Pinocembrin has also been found to play a role in Parkinson's disease, Alzheimer's disease, and specific solid tumors, but its mechanisms of action require in-depth studies."( Advances in Biosynthesis, Pharmacology, and Pharmacokinetics of Pinocembrin, a Promising Natural Small-Molecule Drug.
Liu, Y; Luo, X; Shen, X; Yang, Z, 2019
)
1.47
"Pinocembrin has been shown to have therapeutic effects in AD models."( Pinocembrin protects human brain microvascular endothelial cells against fibrillar amyloid-β(1-40) injury by suppressing the MAPK/NF-κB inflammatory pathways.
Du, GH; Li, JZ; Li, YJ; Liu, R; Song, JK; Sun, JL; Zhang, TT; Zhou, SB, 2014
)
2.57
"Pinocembrin has a variety of pharmacological activities, such as neuroprotective effect, antimicrobial activity, and antioxidant efficacy."( [Progress in synthetic biology of pinocembrin].
Guo, L; Kong, J, 2015
)
1.42

Actions

Pinocembrin (Pino) can inhibit reactive oxygen species (ROS) and cell death in a variety of diseases, such as cardiovascular diseases. The role of Pino in random flaps has not been explored.

ExcerptReferenceRelevance
"Pinocembrin may inhibit the growth of A."( A study of the antibacterial mechanism of pinocembrin against multidrug-resistant Aeromonas hydrophila.
Chen, D; Chen, J; Geng, Y; Huang, X; Liang, C; Miao, Y; Ouyang, P; Wei, W; Wu, J; Wu, Y; Yin, L, 2022
)
1.71
"Pinocembrin may produce these effects by inhibiting the NLRP3 pathway."( Pinocembrin alleviates the susceptibility to atrial fibrillation in isoproterenol-induced rats.
Chen, X; Liu, Z; Wan, W; Yang, B; Ye, T; Yu, Y; Zhang, C, 2022
)
2.89
"Pinocembrin (Pino) can inhibit reactive oxygen species (ROS) and cell death in a variety of diseases, such as cardiovascular diseases, but the role of Pino in random flaps has not been explored."( Pinocembrin alleviates pyroptosis and apoptosis through ROS elimination in random skin flaps via activation of SIRT3.
Chen, H; Diao, W; Jiang, S; Li, J; Li, Y; Lou, J; Wang, X; Xie, Y; Xu, S; Yang, Y; Ye, M, 2023
)
3.07
"Pinocembrin was shown to inhibit both AngII-induced Ca(2+) release from internal stores and Ca(2+) influx."( Pinocembrin inhibits angiotensin II-induced vasoconstriction via suppression of the increase of [Ca2+]i and ERK1/2 activation through blocking AT(1)R in the rat aorta.
Chen, BN; Du, GH; Gao, L; Li, L; Liu, DP; Pang, XB; Wang, L; Wang, SB, 2013
)
2.55

Treatment

Pinocembrin significantly reduced Th2 cytokines interleukin (IL)-4, IL-5 and IL-13 in BALF, and OVA-specific IgE in serum. Treatment with pinoceMbrin increased cell viability dose-dependently, inhibited LDH release and attenuated apoptosis.

ExcerptReferenceRelevance
"Pinocembrin treatment significantly inhibited the formation of NLRP3 inflammasome and infiltration of microglia and enhanced BNIP3-mediated mitophagy in the hippocampus of IH mice."( Pinocembrin ameliorates intermittent hypoxia-induced neuroinflammation through BNIP3-dependent mitophagy in a murine model of sleep apnea.
Gong, LJ; Gu, WY; Wang, XY; Wu, X, 2020
)
2.72
"Pinocembrin-treatment could also reduce the number of TUNEL-positive and Caspase-3-positive neurons, and upregulate the expression of LC3B and Beclin1 in penumbra area."( Pinocembrin protects the brain against ischemia-reperfusion injury and reverses the autophagy dysfunction in the penumbra area.
Du, G; Li, L; Wu, S; Zhang, W; Zhao, G, 2014
)
2.57
"Pinocembrin pretreatment improved renal function and renal Oat3 function and reduced oxidative stress and apoptotic conditions."( Pinocembrin attenuates gentamicin-induced nephrotoxicity in rats.
Arjinajarn, P; Chatsudthipong, V; Chattipakorn, N; Jaikumkao, K; Lungkaphin, A; Pompimon, W; Pongchaidecha, A; Promsan, S, 2016
)
2.6
"Pre-treatment with Pinocembrin attenuated LPS-induced hepatocyte dysfunction and reduced levels of pro-inflammatory factors and macrophages infiltration."( Pinocembrin ameliorates acute liver failure via activating the Sirt1/PPARα pathway in vitro and in vivo.
Cao, P; Chen, Q; Gong, Z; Pei, M; Shi, C; Wang, L, 2022
)
2.48
"Post-treatment with pinocembrin decreased microglial/macrophage activation at 3days, consistent with the recovery of CBF and APTw MRI signals in regions of secondary injury."( Using functional and molecular MRI techniques to detect neuroinflammation and neuroprotection after traumatic brain injury.
Cheng, T; Fan, H; Hong, M; Huang, X; Jiang, S; Lee, DH; Wang, J; Wang, W; Yu, J; Zhang, H; Zhou, J, 2017
)
0.77
"Treatment with pinocembrin significantly reduced Th2 cytokines interleukin (IL)-4, IL-5 and IL-13 in BALF, and OVA-specific IgE in serum."( Pinocembrin attenuates allergic airway inflammation via inhibition of NF-κB pathway in mice.
Du, Q; Gu, X; Shen, H; Zhang, Q; Zhu, Z, 2017
)
2.24
"Treatment with pinocembrin (10(-5), 10(-6), 10(-7) mol/l) increased cell viability dose-dependently, inhibited LDH release and attenuated apoptosis."( Pinocembrin prevents glutamate-induced apoptosis in SH-SY5Y neuronal cells via decrease of bax/bcl-2 ratio.
Du, GH; Gao, M; Hu, JJ; Liu, GT; Liu, QS; Zhang, WC, 2008
)
2.13
"Pretreatment with pinocembrin (30 or 50 microM) also inhibited contractile responses to NE and KCl."( Endothelium-dependent and -independent relaxation induced by pinocembrin in rat aortic rings.
Du, GH; Fang, LH; Li, YJ; Zhu, XM, 2007
)
0.9

Toxicity

ExcerptReferenceRelevance
" No serious adverse events occurred."( Pharmacokinetics, safety, and tolerability of single and multiple-doses of pinocembrin injection administered intravenously in healthy subjects.
Cao, G; Hu, X; Li, K; Shi, A; Sun, T; Xue, W; Yan, B; Yan, J; Ying, P, 2015
)
0.65

Pharmacokinetics

An analytical method enabling the detection and quantification of the individual enantiomers of racemic (±) pinocembrin is required. This method was successfully applied to the pharmacokinetic studies in rats after intravenous administration of pinocembrin.

ExcerptReferenceRelevance
" This method was successfully applied to the pharmacokinetic studies in rats after intravenous administration of pinocembrin."( Development and validation of a high-performance liquid chromatographic method for determination of pinocembrin in rat plasma: application to pharmacokinetic study.
Du, G; Li, X; Liu, Q; Liu, R; Tian, S; Yang, Z, 2009
)
0.78
"An analytical method enabling the detection and quantification of the individual enantiomers of racemic (±) pinocembrin is required to fully characterize its pharmacokinetic disposition."( Chiral analytical method development and application to pre-clinical pharmacokinetics of pinocembrin.
Davies, NM; Martinez, SE; Sayre, CL; Takemoto, JK, 2013
)
0.82
" This analytical method was successful for the determination of pinocembrin in human plasma and applied to a pharmacokinetic study of pinocembrin injection in healthy volunteers after intravenous drip administration."( Determination of pinocembrin in human plasma by solid-phase extraction and LC/MS/MS: application to pharmacokinetic studies.
Cao, G; Hu, X; Li, K; Li, M; Li, Y; Liu, Y; Peng, Y; Shi, A; Sun, T; Xue, W; Yan, B; Yan, J; Zhao, X, 2014
)
0.98
"2-6 h) in serum were observed, while a better estimation of half-life (3-26 h) and other pharmacokinetic parameters were observed using urinary data."( Pre-Clinical Pharmacokinetic and Pharmacodynamic Characterization of Selected Chiral Flavonoids: Pinocembrin and Pinostrobin.
Alrushaid, S; Anderson, HD; Davies, NM; Martinez, SE; Sayre, CL, 2015
)
0.63

Bioavailability

ExcerptReferenceRelevance
" However, low water solubility and bioavailability have hindered its application."( Preparation of Pinocembrin-Loaded F127/MPEG-PDLLA Polymer Micelles and Anti-Osteoporotic Activity.
Adu-Frimpong, M; Cao, X; He, Q; Ji, H; Li, X; Rong, W; Shen, X; Shi, F; Toreniyazov, E; Wang, Q; Xia, X; Xu, X; Yu, J; Zhang, J, 2022
)
1.07

Dosage Studied

ExcerptRelevanceReference
" The fitted model provides a tool to understand the impact of these parameters on the biosensor behavior in terms of dose-response and time curves and offers guidelines to build constructs oriented to increased sensitivity and or ability of linear detection at higher titers."( Building a minimal and generalizable model of transcription factor-based biosensors: Showcasing flavonoids.
Faulon, JL; Koch, M; Trabelsi, H, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (5)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
vasodilator agentA drug used to cause dilation of the blood vessels.
neuroprotective agentAny compound that can be used for the treatment of neurodegenerative disorders.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
dihydroxyflavanoneAny hydroxyflavanone carrying two hydroxy substituents.
(2S)-flavan-4-oneAny flavanone in which the chiral centre at position 2 has S-configuration.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (4)

PathwayProteinsCompounds
chrysin biosynthesis112
pinocembrin C-glucosylation37
pinobanksin biosynthesis115
Flavonoid Biosynthesis1150

Protein Targets (15)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
chromobox protein homolog 1Homo sapiens (human)Potency100.00000.006026.168889.1251AID540317
Guanine nucleotide-binding protein GHomo sapiens (human)Potency7.94331.995325.532750.1187AID624287
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency1.77830.003245.467312,589.2998AID2517
LuciferasePhotinus pyralis (common eastern firefly)Potency16.94410.007215.758889.3584AID588342
ATAD5 protein, partialHomo sapiens (human)Potency24.50920.004110.890331.5287AID504466; AID504467
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency11.22020.28189.721235.4813AID2326
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency89.12510.425612.059128.1838AID504891
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cytochrome P450 1A1Homo sapiens (human)IC50 (µMol)7.90600.00791.24789.9000AID502474
Cytochrome P450 1A2Homo sapiens (human)IC50 (µMol)1.49100.00011.774010.0000AID502473
Serine/threonine-protein kinase pim-1Homo sapiens (human)IC50 (µMol)107.00000.00040.887110.0000AID1798717; AID311148
4-hydroxyphenylpyruvate dioxygenaseArabidopsis thaliana (thale cress)IC50 (µMol)73.00000.07000.16000.2500AID1480423
Cytochrome P450 1B1Homo sapiens (human)IC50 (µMol)1.67900.00130.86969.9000AID502475
Tyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)IC50 (µMol)36.73000.70004.58049.4500AID1803325
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)IC50 (µMol)36.73000.00053.49849.7600AID1803325
M-phase inducer phosphatase 2Homo sapiens (human)IC50 (µMol)36.73000.10002.31039.5100AID1803325
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (190)

Processvia Protein(s)Taxonomy
cellular response to organic cyclic compoundCytochrome P450 1A1Homo sapiens (human)
response to hypoxiaCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid metabolic processCytochrome P450 1A1Homo sapiens (human)
lipid hydroxylationCytochrome P450 1A1Homo sapiens (human)
fatty acid metabolic processCytochrome P450 1A1Homo sapiens (human)
steroid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A1Homo sapiens (human)
steroid metabolic processCytochrome P450 1A1Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A1Homo sapiens (human)
amine metabolic processCytochrome P450 1A1Homo sapiens (human)
response to nematodeCytochrome P450 1A1Homo sapiens (human)
response to herbicideCytochrome P450 1A1Homo sapiens (human)
ethylene metabolic processCytochrome P450 1A1Homo sapiens (human)
coumarin metabolic processCytochrome P450 1A1Homo sapiens (human)
flavonoid metabolic processCytochrome P450 1A1Homo sapiens (human)
response to iron(III) ionCytochrome P450 1A1Homo sapiens (human)
insecticide metabolic processCytochrome P450 1A1Homo sapiens (human)
dibenzo-p-dioxin catabolic processCytochrome P450 1A1Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A1Homo sapiens (human)
response to foodCytochrome P450 1A1Homo sapiens (human)
response to lipopolysaccharideCytochrome P450 1A1Homo sapiens (human)
response to vitamin ACytochrome P450 1A1Homo sapiens (human)
response to immobilization stressCytochrome P450 1A1Homo sapiens (human)
vitamin D metabolic processCytochrome P450 1A1Homo sapiens (human)
retinol metabolic processCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
9-cis-retinoic acid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
camera-type eye developmentCytochrome P450 1A1Homo sapiens (human)
nitric oxide metabolic processCytochrome P450 1A1Homo sapiens (human)
response to arsenic-containing substanceCytochrome P450 1A1Homo sapiens (human)
digestive tract developmentCytochrome P450 1A1Homo sapiens (human)
tissue remodelingCytochrome P450 1A1Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A1Homo sapiens (human)
response to hyperoxiaCytochrome P450 1A1Homo sapiens (human)
maternal process involved in parturitionCytochrome P450 1A1Homo sapiens (human)
hepatocyte differentiationCytochrome P450 1A1Homo sapiens (human)
cellular response to copper ionCytochrome P450 1A1Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A1Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleCytochrome P450 1A1Homo sapiens (human)
response to 3-methylcholanthreneCytochrome P450 1A1Homo sapiens (human)
steroid catabolic processCytochrome P450 1A2Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A2Homo sapiens (human)
cholesterol metabolic processCytochrome P450 1A2Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A2Homo sapiens (human)
toxin biosynthetic processCytochrome P450 1A2Homo sapiens (human)
post-embryonic developmentCytochrome P450 1A2Homo sapiens (human)
alkaloid metabolic processCytochrome P450 1A2Homo sapiens (human)
regulation of gene expressionCytochrome P450 1A2Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 1A2Homo sapiens (human)
dibenzo-p-dioxin metabolic processCytochrome P450 1A2Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
lung developmentCytochrome P450 1A2Homo sapiens (human)
methylationCytochrome P450 1A2Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 1A2Homo sapiens (human)
retinol metabolic processCytochrome P450 1A2Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A2Homo sapiens (human)
cellular respirationCytochrome P450 1A2Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 1A2Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A2Homo sapiens (human)
oxidative demethylationCytochrome P450 1A2Homo sapiens (human)
cellular response to cadmium ionCytochrome P450 1A2Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
protein phosphorylationSerine/threonine-protein kinase pim-1Homo sapiens (human)
apoptotic processSerine/threonine-protein kinase pim-1Homo sapiens (human)
regulation of transmembrane transporter activitySerine/threonine-protein kinase pim-1Homo sapiens (human)
negative regulation of apoptotic processSerine/threonine-protein kinase pim-1Homo sapiens (human)
negative regulation of DNA-binding transcription factor activitySerine/threonine-protein kinase pim-1Homo sapiens (human)
negative regulation of innate immune responseSerine/threonine-protein kinase pim-1Homo sapiens (human)
positive regulation of DNA-templated transcriptionSerine/threonine-protein kinase pim-1Homo sapiens (human)
protein autophosphorylationSerine/threonine-protein kinase pim-1Homo sapiens (human)
protein stabilizationSerine/threonine-protein kinase pim-1Homo sapiens (human)
positive regulation of cardiac muscle cell proliferationSerine/threonine-protein kinase pim-1Homo sapiens (human)
vitamin D receptor signaling pathwaySerine/threonine-protein kinase pim-1Homo sapiens (human)
cellular response to type II interferonSerine/threonine-protein kinase pim-1Homo sapiens (human)
positive regulation of brown fat cell differentiationSerine/threonine-protein kinase pim-1Homo sapiens (human)
regulation of hematopoietic stem cell proliferationSerine/threonine-protein kinase pim-1Homo sapiens (human)
positive regulation of TORC1 signalingSerine/threonine-protein kinase pim-1Homo sapiens (human)
positive regulation of cardioblast proliferationSerine/threonine-protein kinase pim-1Homo sapiens (human)
cellular detoxificationSerine/threonine-protein kinase pim-1Homo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
renal water homeostasisGuanine nucleotide-binding protein GHomo sapiens (human)
G protein-coupled receptor signaling pathwayGuanine nucleotide-binding protein GHomo sapiens (human)
regulation of insulin secretionGuanine nucleotide-binding protein GHomo sapiens (human)
cellular response to glucagon stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
tyrosine catabolic process4-hydroxyphenylpyruvate dioxygenaseArabidopsis thaliana (thale cress)
cellular response to organic cyclic compoundCytochrome P450 1B1Homo sapiens (human)
angiogenesisCytochrome P450 1B1Homo sapiens (human)
trabecular meshwork developmentCytochrome P450 1B1Homo sapiens (human)
DNA modificationCytochrome P450 1B1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1B1Homo sapiens (human)
nitric oxide biosynthetic processCytochrome P450 1B1Homo sapiens (human)
cell adhesionCytochrome P450 1B1Homo sapiens (human)
response to nutrientCytochrome P450 1B1Homo sapiens (human)
steroid metabolic processCytochrome P450 1B1Homo sapiens (human)
estrogen metabolic processCytochrome P450 1B1Homo sapiens (human)
negative regulation of cell population proliferationCytochrome P450 1B1Homo sapiens (human)
male gonad developmentCytochrome P450 1B1Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to oxidative stressCytochrome P450 1B1Homo sapiens (human)
toxin metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionCytochrome P450 1B1Homo sapiens (human)
positive regulation of smooth muscle cell migrationCytochrome P450 1B1Homo sapiens (human)
sterol metabolic processCytochrome P450 1B1Homo sapiens (human)
arachidonic acid metabolic processCytochrome P450 1B1Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1B1Homo sapiens (human)
collagen fibril organizationCytochrome P450 1B1Homo sapiens (human)
adrenal gland developmentCytochrome P450 1B1Homo sapiens (human)
negative regulation of cell migrationCytochrome P450 1B1Homo sapiens (human)
negative regulation of NF-kappaB transcription factor activityCytochrome P450 1B1Homo sapiens (human)
response to follicle-stimulating hormoneCytochrome P450 1B1Homo sapiens (human)
response to estradiolCytochrome P450 1B1Homo sapiens (human)
negative regulation of cell adhesion mediated by integrinCytochrome P450 1B1Homo sapiens (human)
benzene-containing compound metabolic processCytochrome P450 1B1Homo sapiens (human)
retinol metabolic processCytochrome P450 1B1Homo sapiens (human)
retinal metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of apoptotic processCytochrome P450 1B1Homo sapiens (human)
blood vessel endothelial cell migrationCytochrome P450 1B1Homo sapiens (human)
endothelial cell migrationCytochrome P450 1B1Homo sapiens (human)
estrous cycleCytochrome P450 1B1Homo sapiens (human)
positive regulation of translationCytochrome P450 1B1Homo sapiens (human)
positive regulation of angiogenesisCytochrome P450 1B1Homo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATCytochrome P450 1B1Homo sapiens (human)
membrane lipid catabolic processCytochrome P450 1B1Homo sapiens (human)
response to arsenic-containing substanceCytochrome P450 1B1Homo sapiens (human)
blood vessel morphogenesisCytochrome P450 1B1Homo sapiens (human)
retinal blood vessel morphogenesisCytochrome P450 1B1Homo sapiens (human)
ganglion developmentCytochrome P450 1B1Homo sapiens (human)
cellular response to hydrogen peroxideCytochrome P450 1B1Homo sapiens (human)
cellular response to cAMPCytochrome P450 1B1Homo sapiens (human)
cellular response to tumor necrosis factorCytochrome P450 1B1Homo sapiens (human)
cellular response to luteinizing hormone stimulusCytochrome P450 1B1Homo sapiens (human)
cellular response to cortisol stimulusCytochrome P450 1B1Homo sapiens (human)
cellular response to progesterone stimulusCytochrome P450 1B1Homo sapiens (human)
response to dexamethasoneCytochrome P450 1B1Homo sapiens (human)
endothelial cell-cell adhesionCytochrome P450 1B1Homo sapiens (human)
response to indole-3-methanolCytochrome P450 1B1Homo sapiens (human)
cellular response to toxic substanceCytochrome P450 1B1Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1B1Homo sapiens (human)
response to 3-methylcholanthreneCytochrome P450 1B1Homo sapiens (human)
regulation of reactive oxygen species metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of DNA biosynthetic processCytochrome P450 1B1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of cell population proliferationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of tumor necrosis factor-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of lipid storageTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
B cell differentiationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
T cell differentiationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
erythrocyte differentiationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
insulin receptor recyclingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of epidermal growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of tyrosine phosphorylation of STAT proteinTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
glucose homeostasisTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of macrophage differentiationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
positive regulation of gluconeogenesisTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of inflammatory responseTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of T cell receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of chemotaxisTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
regulation of type II interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of type II interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of interleukin-6-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
regulation of hepatocyte growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of interleukin-2-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of interleukin-4-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of macrophage colony-stimulating factor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of positive thymic T cell selectionTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
positive regulation of PERK-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of receptor signaling pathway via JAK-STATTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
positive regulation of JUN kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
actin cytoskeleton organizationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of endocytosisTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of vascular endothelial growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulum unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of intracellular protein transportTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cellular response to unfolded proteinTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor recyclingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of MAP kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STATTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of protein tyrosine kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of hepatocyte growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of PERK-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of receptor catabolic processTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
G2/M transition of mitotic cell cycleM-phase inducer phosphatase 2Homo sapiens (human)
mitotic cell cycleM-phase inducer phosphatase 2Homo sapiens (human)
oocyte maturationM-phase inducer phosphatase 2Homo sapiens (human)
protein phosphorylationM-phase inducer phosphatase 2Homo sapiens (human)
female meiosis IM-phase inducer phosphatase 2Homo sapiens (human)
positive regulation of cell population proliferationM-phase inducer phosphatase 2Homo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycleM-phase inducer phosphatase 2Homo sapiens (human)
positive regulation of cytokinesisM-phase inducer phosphatase 2Homo sapiens (human)
positive regulation of mitotic cell cycleM-phase inducer phosphatase 2Homo sapiens (human)
cell divisionM-phase inducer phosphatase 2Homo sapiens (human)
positive regulation of G2/MI transition of meiotic cell cycleM-phase inducer phosphatase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (47)

Processvia Protein(s)Taxonomy
monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
iron ion bindingCytochrome P450 1A1Homo sapiens (human)
protein bindingCytochrome P450 1A1Homo sapiens (human)
arachidonic acid monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A1Homo sapiens (human)
oxidoreductase activity, acting on diphenols and related substances as donorsCytochrome P450 1A1Homo sapiens (human)
flavonoid 3'-monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
oxygen bindingCytochrome P450 1A1Homo sapiens (human)
enzyme bindingCytochrome P450 1A1Homo sapiens (human)
heme bindingCytochrome P450 1A1Homo sapiens (human)
Hsp70 protein bindingCytochrome P450 1A1Homo sapiens (human)
demethylase activityCytochrome P450 1A1Homo sapiens (human)
Hsp90 protein bindingCytochrome P450 1A1Homo sapiens (human)
aromatase activityCytochrome P450 1A1Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid omega-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid omega-1 hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
monooxygenase activityCytochrome P450 1A2Homo sapiens (human)
iron ion bindingCytochrome P450 1A2Homo sapiens (human)
protein bindingCytochrome P450 1A2Homo sapiens (human)
electron transfer activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1A2Homo sapiens (human)
enzyme bindingCytochrome P450 1A2Homo sapiens (human)
heme bindingCytochrome P450 1A2Homo sapiens (human)
demethylase activityCytochrome P450 1A2Homo sapiens (human)
caffeine oxidase activityCytochrome P450 1A2Homo sapiens (human)
aromatase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A2Homo sapiens (human)
protein serine/threonine kinase activitySerine/threonine-protein kinase pim-1Homo sapiens (human)
protein bindingSerine/threonine-protein kinase pim-1Homo sapiens (human)
ATP bindingSerine/threonine-protein kinase pim-1Homo sapiens (human)
transcription factor bindingSerine/threonine-protein kinase pim-1Homo sapiens (human)
manganese ion bindingSerine/threonine-protein kinase pim-1Homo sapiens (human)
ribosomal small subunit bindingSerine/threonine-protein kinase pim-1Homo sapiens (human)
protein serine kinase activitySerine/threonine-protein kinase pim-1Homo sapiens (human)
G protein activityGuanine nucleotide-binding protein GHomo sapiens (human)
adenylate cyclase activator activityGuanine nucleotide-binding protein GHomo sapiens (human)
4-hydroxyphenylpyruvate dioxygenase activity4-hydroxyphenylpyruvate dioxygenaseArabidopsis thaliana (thale cress)
monooxygenase activityCytochrome P450 1B1Homo sapiens (human)
iron ion bindingCytochrome P450 1B1Homo sapiens (human)
protein bindingCytochrome P450 1B1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1B1Homo sapiens (human)
heme bindingCytochrome P450 1B1Homo sapiens (human)
aromatase activityCytochrome P450 1B1Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1B1Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1B1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygenCytochrome P450 1B1Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
integrin bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
syntaxin bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
STAT family protein bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
RNA bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
zinc ion bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
enzyme bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cadherin bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
ephrin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein phosphatase 2A bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
phosphoprotein phosphatase activityM-phase inducer phosphatase 2Homo sapiens (human)
protein tyrosine phosphatase activityM-phase inducer phosphatase 2Homo sapiens (human)
protein bindingM-phase inducer phosphatase 2Homo sapiens (human)
protein kinase bindingM-phase inducer phosphatase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (21)

Processvia Protein(s)Taxonomy
mitochondrial inner membraneCytochrome P450 1A1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1A1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
nucleusSerine/threonine-protein kinase pim-1Homo sapiens (human)
nucleoplasmSerine/threonine-protein kinase pim-1Homo sapiens (human)
nucleolusSerine/threonine-protein kinase pim-1Homo sapiens (human)
cytoplasmSerine/threonine-protein kinase pim-1Homo sapiens (human)
cytosolSerine/threonine-protein kinase pim-1Homo sapiens (human)
plasma membraneSerine/threonine-protein kinase pim-1Homo sapiens (human)
cytoplasmSerine/threonine-protein kinase pim-1Homo sapiens (human)
plasma membraneGuanine nucleotide-binding protein GHomo sapiens (human)
mitochondrionCytochrome P450 1B1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1B1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1B1Homo sapiens (human)
plasma membraneTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
nucleoplasmTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
endosome lumenTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
nucleusTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
plasma membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial matrixTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial cristaTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endosome lumenTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
sorting endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmic side of endoplasmic reticulum membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
spindle poleM-phase inducer phosphatase 2Homo sapiens (human)
nucleoplasmM-phase inducer phosphatase 2Homo sapiens (human)
centrosomeM-phase inducer phosphatase 2Homo sapiens (human)
cytosolM-phase inducer phosphatase 2Homo sapiens (human)
nucleusM-phase inducer phosphatase 2Homo sapiens (human)
cytoplasmM-phase inducer phosphatase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (176)

Assay IDTitleYearJournalArticle
AID1625187Inhibition of Saccharomyces cerevisiae alpha-glucosidase using p-nitrophenyl alpha-D-glucoside as substrate by colorimetric assay2019Journal of natural products, 04-26, Volume: 82, Issue:4
α-Glucosidase Inhibitory Flavonoids and Oxepinones from the Leaf and Twig Extracts of Desmos cochinchinensis.
AID423363Antimicrobial activity against vancomycin-resistant Enterococcus faecalis after 20 hrs by broth microdilution method2009Journal of natural products, Apr, Volume: 72, Issue:4
Screening of flavonoids as candidate antibiotics against Enterococcus faecalis.
AID334445Chemopreventive activity in Syrian hamster embryo cells assessed as inhibition of metabolism of [3H]benzo(a)pyrene to water-soluble metabolites after 24 hrs at 10 ug/ml relative to control1992Journal of natural products, Mar, Volume: 55, Issue:3
Isolation of potential cancer chemopreventive agents from Eriodictyon californicum.
AID426210Cytotoxicity against human SW1353 cells by neutral red assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora.
AID1264966Cytotoxicity against human MSC assessed as cell viability at 5 uM treated for 3 days measured on day 4 by alamar blue assay (Rvb = 100 +/- 1%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID470664Cytotoxicity against human HeLa cells after 72 hrs by MTT assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Cytotoxic constituents of Soymida febrifuga from Myanmar.
AID426207Cytotoxicity against african green monkey Vero cells upto 50 uM by neutral red assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora.
AID1103946Antifeedant activity against third-instar Spodoptera frugiperda (fall armyworm) measured at 10 ug/cm2 leaf disk after 3 to 4 hr by leaf-disk choice test relative to control2009Bioresource technology, Jul, Volume: 100, Issue:14
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
AID469799Estrogenic activity in human T47D cells assessed as drug level causing stimulation of cell proliferation equivalent to 10 pM estradiol after 96 hrs by alamar blue assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID642356Inhibition of Dengue virus 2 NS5 polymerase-mediated RNA synthesis expressed in Escherichia coli Rosetta pLac1 cells assessed as [3H]GTP incorporation after 5 mins by scintillation counting2011Journal of natural products, Nov-28, Volume: 74, Issue:11
Alkylated flavanones from the bark of Cryptocarya chartacea as dengue virus NS5 polymerase inhibitors.
AID334279Antiproliferative activity against mouse 26-L5 cells after 72 hrs by MTT assay2002Journal of natural products, May, Volume: 65, Issue:5
Constituents of Chinese propolis and their antiproliferative activities.
AID1714000Cytotoxicity against mouse B16-F10 cells assessed as reduction in cell viability incubated for 72 hrs by XTT assay
AID658443Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis mc2 155 assessed as modulation of EtBr-mediated antibacterial activity measuring fractional inhibitory concentration index at 64 mg/L after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis.
AID470662Cytotoxicity against human HT1080 cells after 72 hrs by MTT assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Cytotoxic constituents of Soymida febrifuga from Myanmar.
AID658442Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis mc2 155 assessed as modulation of rifampicin-mediated antibacterial activity measuring ratio of rifampicin MIC to rifampicin and compound MIC at 64 mg/L after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis.
AID1103942Antifeedant activity against third-instar Xanthogaleruca luteola assessed per cm2 leaf disk after 24 hr by leaf-disk choice test2009Bioresource technology, Jul, Volume: 100, Issue:14
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
AID638541Inhibition of Plasmodium falciparum enoyl-ACP reductase assessed as oxidation of NADH to NAD+ after 10 mins by spectrophotometric analysis2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Methylenebissantin: a rare methylene-bridged bisflavonoid from Dodonaea viscosa which inhibits Plasmodium falciparum enoyl-ACP reductase.
AID1558363Antiviral activity against Zika virus PRVABC59 Puerto Rico infected in human JEG3 cells after 24 hrs by plaque assay2020Journal of medicinal chemistry, 01-23, Volume: 63, Issue:2
Drugs for the Treatment of Zika Virus Infection.
AID1103941Antifeedant activity against third-instar Spodoptera frugiperda (fall armyworm) assessed per cm2 leaf disk after 3 to 4 hr by leaf-disk choice test2009Bioresource technology, Jul, Volume: 100, Issue:14
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
AID1264964Cytotoxicity against human MSC assessed as cell viability at 10 uM after 24 hrs measured on day 1 by alamar blue assay (Rvb = 102 +/- 1%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID265722Inhibition of dengue2 virus NS2B/NS3 protease activity for Boc-Gly-Arg-Arg-MCA cleavage at 400 ppm2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease.
AID358173Inhibition of p40 tyrosine kinase1992Journal of natural products, Nov, Volume: 55, Issue:11
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.
AID423365Binding affinity to Enterococcus faecalis KAS3 by fluorescence quenching analysis2009Journal of natural products, Apr, Volume: 72, Issue:4
Screening of flavonoids as candidate antibiotics against Enterococcus faecalis.
AID658581Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis mc2 155 assessed as EtBr accumulation measuring relative fluorescence at half the MIC measured for 60 mins by spectrophotometry relative to control2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis.
AID334277Antiproliferative activity against human A549 cells after 72 hrs by MTT assay2002Journal of natural products, May, Volume: 65, Issue:5
Constituents of Chinese propolis and their antiproliferative activities.
AID658589Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis mc2 155 assessed as modulation of EtBr-mediated antibacterial activity measuring reduction in MIC at 1/2 of MIC after 72 hrs by MTT assay relative to control2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis.
AID431869Effect on AhR-mediated NAPDH quinine reductase activation in mouse Hepa1c1c12 cells at 20 uM after 18 hrs by Western blot analysis2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands.
AID265721Inhibition of dengue2 virus NS2B/NS3 protease activity for Boc-Gly-Arg-Arg-MCA cleavage at 240 ppm2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease.
AID423636Cytotoxicity against human HeLa cells by MTT assay2009Journal of natural products, Apr, Volume: 72, Issue:4
Cytotoxic constituents of chinese propolis.
AID449985Induction of DR5 receptor promotor activity in human DLD1 cells co-transfected with Sac1 at 43.9 uM after 24 hrs by luciferase assay2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID1103952Antifeedant activity against third-instar Xanthogaleruca luteola measured at 10 ug/cm2 leaf disk after 24 hr by leaf-disk choice test relative to control2009Bioresource technology, Jul, Volume: 100, Issue:14
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
AID311568Cytotoxicity against human PANC1 cells assessed as cell viability2007Journal of natural products, Oct, Volume: 70, Issue:10
Bioactive secondary metabolites from Boesenbergia pandurata of Myanmar and their preferential cytotoxicity against human pancreatic cancer PANC-1 cell line in nutrient-deprived medium.
AID1558362Cytotoxicity against human JEG3 cells by alamarBlue assay2020Journal of medicinal chemistry, 01-23, Volume: 63, Issue:2
Drugs for the Treatment of Zika Virus Infection.
AID469803Estrogenic activity in luciferase transfected human MCF7 cells assessed as drug level causing stimulation of cell proliferation equivalent to 10 pM estradiol by luciferase reporter gene assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID404070In vivo antitumor activity against mouse CA-755 cells
AID470661Cytotoxicity against human PANC1 cells in nutrient-deprived condition after 24 hrs by WST8 assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Cytotoxic constituents of Soymida febrifuga from Myanmar.
AID623565Cytotoxicity against human HT-29 cells after 3 days by sulforhodamine B assay2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Bioassay-guided isolation of constituents of Piper sarmentosum using a mitochondrial transmembrane potential assay.
AID1439488Cysticidal activity against Taenia crassiceps cysts after 11 days by trypan blue exclusion method2017European journal of medicinal chemistry, Mar-31, Volume: 129Medicinal plants used as anthelmintics: Ethnomedical, pharmacological, and phytochemical studies.
AID1103955Antifeedant activity against third-instar Epilachna paenulata measured at 100 ug/cm2 leaf disk after 24 hr by leaf-disk choice test relative to control2009Bioresource technology, Jul, Volume: 100, Issue:14
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
AID1264970Cytotoxicity against human MSC assessed as cell viability at 10 uM treated for 6 days measured on day 7 by alamar blue assay (Rvb = 98%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID658437Antibacterial activity against Mycobacterium smegmatis mc2 155 after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis.
AID1103956Antifeedant activity against third-instar Epilachna paenulata measured at 50 ug/cm2 leaf disk after 24 hr by leaf-disk choice test relative to control2009Bioresource technology, Jul, Volume: 100, Issue:14
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
AID404067In vivo antitumor activity against mouse S180 cells
AID1648011Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as reduction in parasite growth at 40 uM incubated for 72 hrs by DAPI staining based fluorescence assay2020Journal of natural products, 02-28, Volume: 83, Issue:2
A Meroisoprenoid, Heptenolides, and
AID1264967Cytotoxicity against human MSC assessed as cell viability at 10 uM treated for 3 days measured on day 4 by alamar blue assay (Rvb = 100 +/- 1%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID470665Cytotoxicity against mouse Colon 26-L5 cells after 72 hrs by MTT assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Cytotoxic constituents of Soymida febrifuga from Myanmar.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1264949Cytotoxicity against human MSC assessed as decrease in cell number at 1 to 10 uM after 9 days by methylene blue staining based microscopy relative to control2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID334275Antiproliferative activity against mouse B16-BL6 cells after 72 hrs by MTT assay2002Journal of natural products, May, Volume: 65, Issue:5
Constituents of Chinese propolis and their antiproliferative activities.
AID402477Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality at 250 uM preincubated for 15 mins before TNFalpha addition measured after 24 hrs by crystal violet staining1997Journal of natural products, Aug, Volume: 60, Issue:8
Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells.
AID469804Estrogenic activity in luciferase transfected human MCF7 cells assessed as drug level causing stimulation of cell proliferation equivalent to 100 pM estradiol by luciferase reporter gene assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID423362Antimicrobial activity against Enterococcus faecalis after 20 hrs by broth microdilution method2009Journal of natural products, Apr, Volume: 72, Issue:4
Screening of flavonoids as candidate antibiotics against Enterococcus faecalis.
AID756489Cytotoxicity against mouse RAW264.7 cells by CCK assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Inhibitory constituents of the heartwood of Dalbergia odorifera on nitric oxide production in RAW 264.7 macrophages.
AID1103945Antifeedant activity against third-instar Spodoptera frugiperda (fall armyworm) measured at 50 ug/cm2 leaf disk after 3 to 4 hr by leaf-disk choice test relative to control2009Bioresource technology, Jul, Volume: 100, Issue:14
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
AID1103958Antifeedant activity against third-instar Epilachna paenulata measured at 5 ug/cm2 leaf disk after 24 hr by leaf-disk choice test relative to control2009Bioresource technology, Jul, Volume: 100, Issue:14
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
AID431870Induction of nuclear translocation of AhR from cytosol in mouse Hepa1 cells at 20 uM after 60 mins using DAPI staining by microscopic analysis2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands.
AID469800Estrogenic activity in human MCF7 cells assessed as drug level causing stimulation of cell proliferation equivalent to 100 pM estradiol after 96 hrs by alamar blue assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID1264947Induction of osteogenic differentiation in human MSC assessed as increase in ALP activity at 10 uM using p-NPP as substrate after 9 days by colorimetric method relative to control2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID658444Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis mc2 155 assessed as modulation of rifampicin-mediated antibacterial activity measuring fractional inhibitory concentration index at 64 mg/L after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis.
AID1264946Induction of osteogenic differentiation in human MSC assessed as increase in ALP activity at 5 uM using p-NPP as substrate after 9 days by colorimetric method relative to control2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID1264968Cytotoxicity against human MSC assessed as cell viability at 1 uM treated for 6 days measured on day 7 by alamar blue assay (Rvb = 98%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID1480423Inhibition of Arabidopsis thaliana HPPD expressed in Escherichia coli JM105 using HPPA as substrate after preincubated for 15 min followed by substrate addition by HPLC analysis2017Journal of medicinal chemistry, 05-25, Volume: 60, Issue:10
4-Hydroxyphenylpyruvate Dioxygenase and Its Inhibition in Plants and Animals: Small Molecules as Herbicides and Agents for the Treatment of Human Inherited Diseases.
AID1713991Inhibition of monophenolase activity of mushroom tyrosinase using L-Tyrosine substrate incubated for 5 mins followed by substrate addition and measured for 30 mins by colorimetry
AID1103950Antifeedant activity against third-instar Xanthogaleruca luteola measured at 100 ug/cm2 leaf disk after 24 hr by leaf-disk choice test relative to control2009Bioresource technology, Jul, Volume: 100, Issue:14
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID658441Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis mc2 155 assessed as modulation of isoniazid-mediated antibacterial activity measuring ratio of isoniazid MIC to isoniazid and compound MIC at 64 mg/L after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis.
AID426214Cytotoxicity against human KB cells upto 50 uM by neutral red assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora.
AID334278Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay2002Journal of natural products, May, Volume: 65, Issue:5
Constituents of Chinese propolis and their antiproliferative activities.
AID470663Cytotoxicity against human A549 cells after 72 hrs by MTT assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Cytotoxic constituents of Soymida febrifuga from Myanmar.
AID431868Effect on AhR-mediated CYP1A1 activation in mouse Hepa1c1c12 cells at 20 uM after 18 hrs by Western blot analysis2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands.
AID469806Estrogenic activity in luciferase transfected human T47D cells assessed as drug level causing stimulation of cell proliferation equivalent to 100 pM estradiol by luciferase reporter gene assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID426212Cytotoxicity against human HepG2 cells upto 50 uM by neutral red assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora.
AID469805Estrogenic activity in luciferase transfected human T47D cells assessed as drug level causing stimulation of cell proliferation equivalent to 10 pM estradiol by luciferase reporter gene assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID426208Cytotoxicity against pig LLC-PK11 cells upto 50 uM by neutral red assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora.
AID431863Induction of mouse AhR LBD transcriptional activity in mouse hepa1 cells transfected with AhR response element co expressed with XRE after 6 hrs by luciferase reporter gene assay relative to control2009Journal of medicinal chemistry, Sep-24, Volume: 52, Issue:18
Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands.
AID311148Inhibition of PIM1 kinase2007Bioorganic & medicinal chemistry, Oct-01, Volume: 15, Issue:19
Comparative molecular field analysis of flavonoid inhibitors of the PIM-1 kinase.
AID1264962Cytotoxicity against human MSC assessed as cell viability at 1 uM measured on day 1 by alamar blue assay (Rvb = 102 +/- 1%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID426213Cytotoxicity against human SK-MEL cells upto 50 uM by neutral red assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora.
AID1103951Antifeedant activity against third-instar Xanthogaleruca luteola measured at 50 ug/cm2 leaf disk after 24 hr by leaf-disk choice test relative to control2009Bioresource technology, Jul, Volume: 100, Issue:14
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
AID1264963Cytotoxicity against human MSC assessed as cell viability at 5 uM after 24 hrs measured on day 1 by alamar blue assay (Rvb = 102 +/- 1%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID334446Chemopreventive activity in Syrian hamster embryo cells assessed as inhibition of metabolism of [3H]benzo(a)pyrene to water-soluble metabolites after 24 hrs at 5 ug/ml relative to control1992Journal of natural products, Mar, Volume: 55, Issue:3
Isolation of potential cancer chemopreventive agents from Eriodictyon californicum.
AID502473Inhibition of human CYP1A2 by EROD assay2010Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
AID713894Antimycobacterial activity against Mycobacterium tuberculosis H37Ra2012European journal of medicinal chemistry, Mar, Volume: 49Recent advances in antitubercular natural products.
AID333447Antifungal activity against Cladosporium sphaerospermum assessed as minimum concentration required to inhibit growth after 72 hrs by TLC2004Journal of natural products, Nov, Volume: 67, Issue:11
Benzoic acid derivatives from Piper species and their fungitoxic activity against Cladosporium cladosporioides and C. sphaerospermum.
AID1167300Antioxidant activity assessed as DPPH radical scavenging activity incubated at room temperature for 20 mins by UV-visible spectrophotometry2014Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21
Design, synthesis and exploring the quantitative structure-activity relationship of some antioxidant flavonoid analogues.
AID1103957Antifeedant activity against third-instar Epilachna paenulata measured at 10 ug/cm2 leaf disk after 24 hr by leaf-disk choice test relative to control2009Bioresource technology, Jul, Volume: 100, Issue:14
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
AID470666Cytotoxicity against mouse B16-BL6 cells after 72 hrs by MTT assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Cytotoxic constituents of Soymida febrifuga from Myanmar.
AID658591Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis mc2 155 assessed as modulation of ethambutol-mediated antibacterial activity measuring reduction in MIC at 1/2 of MIC after 72 hrs by MTT assay relative to control2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis.
AID1103954Antifeedant activity against third-instar Xanthogaleruca luteola measured at 1 ug/cm2 leaf disk after 24 hr by leaf-disk choice test relative to control2009Bioresource technology, Jul, Volume: 100, Issue:14
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
AID334276Antiproliferative activity against human HT1080 cells after 72 hrs by MTT assay2002Journal of natural products, May, Volume: 65, Issue:5
Constituents of Chinese propolis and their antiproliferative activities.
AID1103944Antifeedant activity against third-instar Spodoptera frugiperda (fall armyworm) measured at 100 ug/cm2 leaf disk after 3 to 4 hr by leaf-disk choice test relative to control2009Bioresource technology, Jul, Volume: 100, Issue:14
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
AID469802Estrogenic activity in human MCF7 cells assessed as drug level causing stimulation of cell proliferation equivalent to 10 pM estradiol after 96 hrs by alamar blue assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID1264965Cytotoxicity against human MSC assessed as cell viability at 1 uM treated for 3 days measured on day 4 by alamar blue assay (Rvb = 100 +/- 1%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID1103948Antifeedant activity against third-instar Spodoptera frugiperda (fall armyworm) measured at 5 ug/cm2 leaf disk after 3 to 4 hr by leaf-disk choice test relative to control2009Bioresource technology, Jul, Volume: 100, Issue:14
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
AID336952Inhibition of bovine thymocytes protein tyrosine kinase assessed as angiotensin 1 phosphorylation
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID756490Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Inhibitory constituents of the heartwood of Dalbergia odorifera on nitric oxide production in RAW 264.7 macrophages.
AID658439Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis mc2 155 assessed as modulation of ciprofloxacin-mediated antibacterial activity measuring ratio of ciprofloxacin MIC to ciprofloxacin and compound MIC at 64 mg/L after 72 hrs by MTT2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis.
AID449984Induction of DR5 receptor promotor activity in human DLD1 cells co-transfected with Sac1 at 39 uM after 24 hrs by luciferase assay2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID480465Cytotoxicity against human KB cells after 3 days by Resazurin Microplate Assay2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
Cytotoxicity against KB and NCI-H187 cell lines of modified flavonoids from Kaempferia parviflora.
AID334444Chemopreventive activity in Syrian hamster embryo cells assessed as inhibition of metabolism of [3H]benzo(a)pyrene to water-soluble metabolites after 24 hrs at 20 ug/ml relative to control1992Journal of natural products, Mar, Volume: 55, Issue:3
Isolation of potential cancer chemopreventive agents from Eriodictyon californicum.
AID623566Induction of apoptosis in human HT-29 cells assessed reduction of mitochondrial membrane potential after 2 hrs by using JC1 staining by fluorescence cell-based assay2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Bioassay-guided isolation of constituents of Piper sarmentosum using a mitochondrial transmembrane potential assay.
AID1264945Induction of osteogenic differentiation in human MSC assessed as increase in ALP activity at 1 uM using p-NPP as substrate after 9 days by colorimetric method relative to control2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID426211Inhibition of SP1-dependent luciferase expression2009Journal of natural products, Jun, Volume: 72, Issue:6
Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora.
AID658440Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis mc2 155 assessed as modulation of ethambutol-mediated antibacterial activity measuring ratio of ethambutol MIC to ethambutol and compound MIC at 64 mg/L after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis.
AID1742984Cytotoxicity against Sprague-Dawley rat primary cerebellar granule neurons assessed as reduction in cell viability measured after 48 hrs by MTT assay2020European journal of medicinal chemistry, Nov-15, Volume: 206Neuroprotective effects of prenylated flavanones isolated from Dalea species, in vitro and in silico studies.
AID1648012Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2 assessed as reduction in parasite growth at 40 uM incubated for 72 hrs by DAPI staining based fluorescence assay2020Journal of natural products, 02-28, Volume: 83, Issue:2
A Meroisoprenoid, Heptenolides, and
AID469801Estrogenic activity in human T47D cells assessed as drug level causing stimulation of cell proliferation equivalent to 100 pM estradiol after 96 hrs by alamar blue assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID426216Cytotoxicity against human SKOV3 cells upto 50 uM by neutral red assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora.
AID1666593Induction of DNA damage in human SU8686 cells assessed as increase in gammaH2AX phosphorylation at ser193 at cytotoxic IC50 incubated for 24 hrs by fluorometry method2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
Targeting the DNA damage response (DDR) by natural compounds.
AID456268Antiallergic activity in Ca(2+)-stimulated differentiated human HeLa cells assessed as inhibition of cys-leukotriene release after 6 days by ELISA2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Inhibitory activity of Brazilian green propolis components and their derivatives on the release of cys-leukotrienes.
AID265719Inhibition of dengue2 virus NS2B/NS3 protease activity for Boc-Gly-Arg-Arg-MCA cleavage at 120 ppm2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease.
AID333446Antifungal activity against Cladosporium cladosporioides assessed as minimum concentration required to inhibit growth after 72 hrs by TLC2004Journal of natural products, Nov, Volume: 67, Issue:11
Benzoic acid derivatives from Piper species and their fungitoxic activity against Cladosporium cladosporioides and C. sphaerospermum.
AID477928Cytotoxicity against human PANC1 cells in nutrient-deprived condition assessed as preferential cell death after 24 hrs by trypan blue dye exclusion method2010Journal of natural products, Apr-23, Volume: 73, Issue:4
Study on the constituents of Mexican propolis and their cytotoxic activity against PANC-1 human pancreatic cancer cells.
AID1625186Inhibition of Saccharomyces cerevisiae alpha-glucosidase at 200 ug/mL using p-nitrophenyl alpha-D-glucoside as substrate by colorimetric assay2019Journal of natural products, 04-26, Volume: 82, Issue:4
α-Glucosidase Inhibitory Flavonoids and Oxepinones from the Leaf and Twig Extracts of Desmos cochinchinensis.
AID1264969Cytotoxicity against human MSC assessed as cell viability at 5 uM treated for 6 days measured on day 7 by alamar blue assay (Rvb = 98%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID642358Growth inhibition of human KB cells at 10 ug/ml2011Journal of natural products, Nov-28, Volume: 74, Issue:11
Alkylated flavanones from the bark of Cryptocarya chartacea as dengue virus NS5 polymerase inhibitors.
AID623567Inhibition of chymotrypsin-like activity of purified human 20S proteasome in HL60 cells using N-succinyl-Leu-Leu-Val-Tyr-AMC as substrate pre-incubated for 10 mins by fluorimetric assay2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Bioassay-guided isolation of constituents of Piper sarmentosum using a mitochondrial transmembrane potential assay.
AID404069In vivo antitumor activity against mouse L1210 cells
AID1103959Antifeedant activity against third-instar Epilachna paenulata measured at 1 ug/cm2 leaf disk after 24 hr by leaf disk choice test relative to control2009Bioresource technology, Jul, Volume: 100, Issue:14
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
AID402478Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality at 250 uM after 15 mins by [methyl-3H]thymidine incorporation assay1997Journal of natural products, Aug, Volume: 60, Issue:8
Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells.
AID502475Inhibition of human CYP1B1 by EROD assay2010Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1714005Inhibition of melanin production in mouse B16-F10 cells at 12.5 ug/ml relative to control
AID1103943Antifeedant activity against third-instar Epilachna paenulata measured assessed per cm2 leaf disk after 24 hr by leaf disk choice test2009Bioresource technology, Jul, Volume: 100, Issue:14
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
AID658586Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis mc2 155 assessed as inhibition of EtBr efflux measuring normalized fluorescence at half the MIC measured for 60 mins by spectrophotometry relative to control2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis.
AID658438Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis mc2 155 assessed as modulation of EtBr-mediated antibacterial activity measuring ratio of EtBr MIC to EtBr and compound MIC at 64 mg/L after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis.
AID480467Cytotoxicity against human NCI-H187 cells after 5 days by Resazurin Microplate Assay2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
Cytotoxicity against KB and NCI-H187 cell lines of modified flavonoids from Kaempferia parviflora.
AID1742988Neuroprotective activity against H2O2-induced neuronal death in Sprague-Dawley rat primary cerebellar granule neurons assessed as increase in cell viability at 0.5 to 300 uM preincubated for 24 hrs followed by H2O2 addition and measured after 24 hrs by MT2020European journal of medicinal chemistry, Nov-15, Volume: 206Neuroprotective effects of prenylated flavanones isolated from Dalea species, in vitro and in silico studies.
AID426215Cytotoxicity against human BT549 cells upto 50 uM by neutral red assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora.
AID1103953Antifeedant activity against third-instar Xanthogaleruca luteola measured at 5 ug/cm2 leaf disk after 24 hr by leaf-disk choice test relative to control2009Bioresource technology, Jul, Volume: 100, Issue:14
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
AID353303Increase in EGR1 mRNA expression in human HEK293 cells at 20 ug/mL after 6 to 12 hrs by dual-glo luciferase assay relative to control2009Bioorganic & medicinal chemistry letters, Apr-15, Volume: 19, Issue:8
Relationships between the structures of flavanone derivatives and their effects in enhancing early growth response-1 gene expression.
AID502474Inhibition of human CYP1A1 by EROD assay2010Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1798717Solid-Phase ELISA Kinase Assay from Article 10.1158/1535-7163.MCT-06-0397: \\Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase.\\2007Molecular cancer therapeutics, Jan, Volume: 6, Issue:1
Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1331857Antimicrobial activity against Staphylococcus aureus ATCC 29213 at 20 ug/ml by broth microdilution method2016Journal of natural products, 09-23, Volume: 79, Issue:9
Bioactive Formylated Flavonoids from Eugenia rigida: Isolation, Synthesis, and X-ray Crystallography.
AID1331844Antimicrobial activity against Candida glabrata ATCC 90030 after 46 to 50 hrs by broth microdilution method2016Journal of natural products, 09-23, Volume: 79, Issue:9
Bioactive Formylated Flavonoids from Eugenia rigida: Isolation, Synthesis, and X-ray Crystallography.
AID1331862Cytotoxicity against human SK-MEL cells assessed as reduction in cell viability after 48 hrs by neutral red dye-based assay2016Journal of natural products, 09-23, Volume: 79, Issue:9
Bioactive Formylated Flavonoids from Eugenia rigida: Isolation, Synthesis, and X-ray Crystallography.
AID1434690Inhibition of sucrose loaded POPC/POPE/POPS/PtdIns(3,4,5)P3 (59:20:20:1) liposome binding to eGFP-fused PDK1 PH domain (unknown origin) expressed in Escherichia coli BL21 at 20 uM after 10 mins by fluorescence spectrophotometry based pull down assay relat2017Bioorganic & medicinal chemistry letters, 02-01, Volume: 27, Issue:3
Inhibitory potential of flavonoids on PtdIns(3,4,5)P3 binding with the phosphoinositide-dependent kinase 1 pleckstrin homology domain.
AID1331864Cytotoxicity against human BT549 cells assessed as reduction in cell viability after 48 hrs by neutral red dye-based assay2016Journal of natural products, 09-23, Volume: 79, Issue:9
Bioactive Formylated Flavonoids from Eugenia rigida: Isolation, Synthesis, and X-ray Crystallography.
AID1331865Cytotoxicity against human SKOV3 cells assessed as reduction in cell viability after 48 hrs by neutral red dye-based assay2016Journal of natural products, 09-23, Volume: 79, Issue:9
Bioactive Formylated Flavonoids from Eugenia rigida: Isolation, Synthesis, and X-ray Crystallography.
AID1331860Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 at 20 ug/ml by broth microdilution method2016Journal of natural products, 09-23, Volume: 79, Issue:9
Bioactive Formylated Flavonoids from Eugenia rigida: Isolation, Synthesis, and X-ray Crystallography.
AID1331847Antimicrobial activity against Candida krusei ATCC 6258 after 46 to 50 hrs by broth microdilution method2016Journal of natural products, 09-23, Volume: 79, Issue:9
Bioactive Formylated Flavonoids from Eugenia rigida: Isolation, Synthesis, and X-ray Crystallography.
AID1331853Antimicrobial activity against Cryptococcus neoformans ATCC 90113 after 70 to 74 hrs by broth microdilution method2016Journal of natural products, 09-23, Volume: 79, Issue:9
Bioactive Formylated Flavonoids from Eugenia rigida: Isolation, Synthesis, and X-ray Crystallography.
AID1331843Antimicrobial activity against Candida albicans ATCC 90028 at 20 ug/ml after 46 to 50 hrs by broth microdilution method2016Journal of natural products, 09-23, Volume: 79, Issue:9
Bioactive Formylated Flavonoids from Eugenia rigida: Isolation, Synthesis, and X-ray Crystallography.
AID1331867Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability after 48 hrs by neutral red dye-based assay2016Journal of natural products, 09-23, Volume: 79, Issue:9
Bioactive Formylated Flavonoids from Eugenia rigida: Isolation, Synthesis, and X-ray Crystallography.
AID1331863Cytotoxicity against human KB cells assessed as reduction in cell viability after 48 hrs by neutral red dye-based assay2016Journal of natural products, 09-23, Volume: 79, Issue:9
Bioactive Formylated Flavonoids from Eugenia rigida: Isolation, Synthesis, and X-ray Crystallography.
AID1331866Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 48 hrs by neutral red dye-based assay2016Journal of natural products, 09-23, Volume: 79, Issue:9
Bioactive Formylated Flavonoids from Eugenia rigida: Isolation, Synthesis, and X-ray Crystallography.
AID1331851Antimicrobial activity against Aspergillus fumigatus ATCC 204305 at 20 ug/ml after 46 to 50 hrs by broth microdilution method2016Journal of natural products, 09-23, Volume: 79, Issue:9
Bioactive Formylated Flavonoids from Eugenia rigida: Isolation, Synthesis, and X-ray Crystallography.
AID1331868Cytotoxicity against pig LLC-PK1 cells assessed as reduction in cell viability after 48 hrs by neutral red dye-based assay2016Journal of natural products, 09-23, Volume: 79, Issue:9
Bioactive Formylated Flavonoids from Eugenia rigida: Isolation, Synthesis, and X-ray Crystallography.
AID1803325Enzymatic Assay from Article 10.3109/14756366.2012.723206: \\Synthesis and characterization of 5,7-dihydroxyflavanone derivatives as novel protein tyrosine phosphatase 1B inhibitors.\\2013Journal of enzyme inhibition and medicinal chemistry, Dec, Volume: 28, Issue:6
Synthesis and characterization of 5,7-dihydroxyflavanone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (237)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (0.42)18.7374
1990's6 (2.53)18.2507
2000's34 (14.35)29.6817
2010's139 (58.65)24.3611
2020's57 (24.05)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index42.59 (24.57)
Research Supply Index5.50 (2.92)
Research Growth Index5.78 (4.65)
Search Engine Demand Index61.68 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (42.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.41%)5.53%
Trials0 (0.00%)5.53%
Reviews16 (6.58%)6.00%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other226 (93.00%)84.16%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]